The Anti-HCV IgM Diagnostic Test is a critical blood test used to detect the **acute** (recent) phase of Hepatitis C Virus (HCV) infection. When the body first encounters HCV, the immune system rapidly produces immunoglobulin M (IgM) antibodies as the initial, short-lived response.

Detecting anti-HCV IgM specifically suggests a new infection, typically appearing within weeks of exposure. However, this antibody naturally declines as the body transitions to producing long-term IgG antibodies (the marker for chronic infection). Clinical interpretation is complex: a positive IgM test requires confirmation with HCV RNA testing to verify the active presence of the virus and differentiate an early, acute infection from potential chronic reactivity.